Marketdash
Back to Stock Market News

Pre-Market Movers: Ryvyl Tumbles on Reverse Stock Split, NeoGenomics Declines Despite Board Addition

MarketDash Editorial Team
3 hours ago
U.S. stock futures held steady Tuesday morning while several stocks saw notable pre-market declines. Ryvyl plunged over 14% after announcing a reverse split to meet Nasdaq requirements, while NeoGenomics dropped despite positive board news.

U.S. stock futures were trading mostly flat Tuesday morning, with Dow futures inching up just 0.01%. But beneath that calm surface, several stocks were having a rough start to the day.

The biggest decliner was Ryvyl Inc. (RVYL), which tumbled 14.4% to $0.13 in pre-market trading. The payment solutions company announced a 1-for-35 reverse stock split as it tries to regain compliance with Nasdaq's $1 minimum bid price requirement. Reverse splits are never great optics—they reduce your share count while maintaining the same market cap, essentially acknowledging your stock has fallen too far.

Other Notable Pre-Market Decliners

Mink Therapeutics Inc. (INKT) dropped 13.4% to $10.50 in early trading, continuing volatility in the biotech sector.

SMX (Security Matters) PLC (SMX) slipped another 8.2% to $78.00 after already declining 27% on Monday—a brutal two-day stretch for the authentication technology company.

NeoGenomics, Inc. (NEO) fell 7.1% to $11.43, which is particularly interesting since the company actually announced positive news. They named diagnostics and lab services veteran John P. "Jack" Kenny to their Board of Directors. Sometimes the market just isn't in the mood to celebrate good news.

CryoPort Inc. (CYRX) dropped 5% to $9.10, while agilon health, inc. (AGL) declined 4.3% to $0.7060 in pre-market action.

Global Business Travel Group, Inc. (GBTG) lost 3.1% to $7.45, Ambiq Micro, Inc. (AMBQ) slipped 2.6% to $28.40, and Yum China Holdings, Inc. (YUMC) fell 2.1% to $47.50 to round out the morning's decliners.

Back to Stock Market News

Pre-Market Movers: Ryvyl Tumbles on Reverse Stock Split, NeoGenomics Declines Despite Board Addition

MarketDash Editorial Team
3 hours ago
U.S. stock futures held steady Tuesday morning while several stocks saw notable pre-market declines. Ryvyl plunged over 14% after announcing a reverse split to meet Nasdaq requirements, while NeoGenomics dropped despite positive board news.

U.S. stock futures were trading mostly flat Tuesday morning, with Dow futures inching up just 0.01%. But beneath that calm surface, several stocks were having a rough start to the day.

The biggest decliner was Ryvyl Inc. (RVYL), which tumbled 14.4% to $0.13 in pre-market trading. The payment solutions company announced a 1-for-35 reverse stock split as it tries to regain compliance with Nasdaq's $1 minimum bid price requirement. Reverse splits are never great optics—they reduce your share count while maintaining the same market cap, essentially acknowledging your stock has fallen too far.

Other Notable Pre-Market Decliners

Mink Therapeutics Inc. (INKT) dropped 13.4% to $10.50 in early trading, continuing volatility in the biotech sector.

SMX (Security Matters) PLC (SMX) slipped another 8.2% to $78.00 after already declining 27% on Monday—a brutal two-day stretch for the authentication technology company.

NeoGenomics, Inc. (NEO) fell 7.1% to $11.43, which is particularly interesting since the company actually announced positive news. They named diagnostics and lab services veteran John P. "Jack" Kenny to their Board of Directors. Sometimes the market just isn't in the mood to celebrate good news.

CryoPort Inc. (CYRX) dropped 5% to $9.10, while agilon health, inc. (AGL) declined 4.3% to $0.7060 in pre-market action.

Global Business Travel Group, Inc. (GBTG) lost 3.1% to $7.45, Ambiq Micro, Inc. (AMBQ) slipped 2.6% to $28.40, and Yum China Holdings, Inc. (YUMC) fell 2.1% to $47.50 to round out the morning's decliners.